Merck & Co Inc
NYSE:MRK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Merck & Co Inc
NYSE:MRK
|
US |
|
ContextVision AB
OSE:CONTX
|
SE |
|
UFP Technologies Inc
NASDAQ:UFPT
|
US |
|
Bilfinger SE
XETRA:GBF
|
DE |
|
Karooooo Ltd
NASDAQ:KARO
|
SG |
|
Nephros Inc
NASDAQ:NEPH
|
US |
|
Asahi Holdings Inc
TSE:5857
|
JP |
Wall St Price Targets
MRK Price Targets Summary
Merck & Co Inc
According to Wall Street analysts, the average 1-year price target for MRK is 131.75 USD with a low forecast of 101 USD and a high forecast of 157.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MRK's stock price target?
Price Target
131.75
USD
According to Wall Street analysts, the average 1-year price target for MRK is 131.75 USD with a low forecast of 101 USD and a high forecast of 157.5 USD.
What is the Revenue forecast for Merck & Co Inc?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Merck & Co Inc?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 8 years is 2%.
What is the Net Income forecast for Merck & Co Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 8 years is 4%.
